{"product_id":"business-models-and-technologies-in-the-biopharma-and-medical-sectors","title":"Business Models \u0026 Technologies in the Biopharma and Medical Sectors","description":"\u003cp\u003eThis specialised package addresses the strategic and operational frameworks that govern how value is created, delivered and captured in the biopharmaceutical and medical sectors — from originator and biosimilar development models, contract development and manufacturing (CDMO), licensing and co-development structures, to digital-health platforms, personalised medicine and advanced-therapy technologies. Structured as a documented management system, it provides a quality manual that frames the business-model governance approach; procedures for market and technology assessment, business-model design and validation, partnership and licensing evaluation, regulatory-pathway alignment, technology adoption and portfolio review; forms and record templates for opportunity screening, due-diligence, business-case development and stage-gate decisions; checklists for model-selection and technology-readiness reviews; guidance documents describing the principal business models and enabling technologies of the sector with their risk and revenue profiles; and training materials for leadership and business-development teams. The package is designed for pharmaceutical and medical-device companies, health-sector investors, incubators, consultancies and government bodies shaping life-science strategy. It enables systematic evaluation of new ventures and technologies, disciplined go\/no-go decision-making, and alignment of commercial models with regulatory and market-access realities. Benefits include faster and better-evidenced strategic decisions, reduced investment risk, a shared analytical vocabulary across commercial, scientific and regulatory functions, and a repeatable process for renewing the business model as technologies and reimbursement environments evolve.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eIncluded:\u003c\/strong\u003e 43 ready-to-use, fully editable documents (manual, procedures, forms, records, checklists, guidance and training material).\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eLicense:\u003c\/strong\u003e single-organization license; delivered electronically as a ZIP archive.\u003c\/p\u003e","brand":"Apex Global Solutions AGS","offers":[{"title":"Default Title","offer_id":56517077565780,"sku":"AGS-12-004","price":1290.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1052\/4996\/4372\/files\/Business-Models-Technologies-in-the-Biopharma-and-Medical-Sectors.png?v=1784574604","url":"https:\/\/agskits.com\/products\/business-models-and-technologies-in-the-biopharma-and-medical-sectors","provider":"apex global solutions","version":"1.0","type":"link"}